(Q85408356)

English

Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination

scientific article published on 08 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

M Prelog

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

G Almanzar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

N Rieber

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

B Ottensmeier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

M Zlamy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J Liese

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

8 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

387-393

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Update on pertussis in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

What is new in pertussis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Rationale for pertussis booster vaccination throughout life in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Control systems and decision making for antibody production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Immunological memory and protective immunity: understanding their relation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Reactogenicity of tetanus, diphtheria, 5-component acellular pertussis vaccine administered as a sixth consecutive acellular pertussis vaccine dose to adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Immune responses to Bordetella pertussis infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Somatic hypermutation of immunoglobulin genes in human neonates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Somatic mutation of immunoglobulin V(H)6 genes in human infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Competence and competition: the challenge of becoming a long-lived plasma cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Duration of humoral immunity to common viral and vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Maintenance of serological memory by polyclonal activation of human memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.105

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.10.105

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142306%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85408356&oldid=2115030635"